Sensitivity to first-line chemotherapy for metastatic breast cancer in CHEK2 1100delC mutation carriers is not different compared with sporadic breast cancer patients

被引：0
|
作者：
Kriege, M. [1 ]
Jager, A. [1 ]
Hollestelle, A. [1 ]
Berns, P. M. J. J. [1 ]
Sieuwerts, A. M. [1 ]
Collee, J. M. [1 ]
Kroep, J. R. [2 ]
Martens, J. W. M. [1 ]
Hooning, M. J. [1 ]
Seynaeve, C. [1 ]
机构：
[1] Erasmus MC Canc Inst, Rotterdam, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [1] Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
    Mieke Kriege
    Agnes Jager
    Antoinette Hollestelle
    Els M. J. J. Berns
    Jannet Blom
    Marion E. Meijer-van Gelder
    Anieta M. Sieuwerts
    Ans van den Ouweland
    J. Margriet Collée
    Judith R. Kroep
    John W. M. Martens
    Maartje J. Hooning
    Caroline Seynaeve
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1879 - 1887
  • [2] Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hollestelle, Antoinette
    Berns, Els M. J. J.
    Blom, Jannet
    Meijer-van Gelder, Marion E.
    Sieuwerts, Anieta M.
    van den Ouweland, Ans
    Collee, J. Margriet
    Kroep, Judith R.
    Martens, John W. M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1879 - 1887
  • [3] CHEK2:1100delC mutation and elevated breast cancer risk
    Pereira, LHM
    Sigurdson, AJ
    Doody, MM
    Pineda, MA
    Alexander, BH
    Greene, MH
    Struewing, JP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 256 - 256
  • [4] CHEK2 1100delC mutation is frequent among Russian breast cancer patients
    Chekmariova, Elena V.
    Sokolenko, Anna P.
    Buslov, Konstantin G.
    Iyevleva, Aglaya G.
    Ulibina, Yulia M.
    Rozanov, Maxim E.
    Mitiushkina, Natalia V.
    Togo, Alexandr V.
    Matsko, Dmitry E.
    Voskresenskiy, Dmitry A.
    Chagunava, Oleg L.
    Devilee, Peter
    Cornelisse, Cees
    Semiglazov, Vladimir F.
    Imyanitov, Evgeny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 99 - 102
  • [5] CHEK2 1100delC mutation is frequent among Russian breast cancer patients
    Elena V. Chekmariova
    Anna P. Sokolenko
    Konstantin G. Buslov
    Aglaya G. Iyevleva
    Yulia M. Ulibina
    Maxim E. Rozanov
    Natalia V. Mitiushkina
    Alexandr V. Togo
    Dmitry E. Matsko
    Dmitry A. Voskresenskiy
    Oleg L. Chagunava
    Peter Devilee
    Cees Cornelisse
    Vladimir F. Semiglazov
    Evgeny N. Imyanitov
    Breast Cancer Research and Treatment, 2006, 100 : 99 - 102
  • [6] Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers
    Annegien Broeks
    Lot de Witte
    Anke Nooijen
    Angelina Huseinovic
    Jan G.M. Klijn
    Flora E. van Leeuwen
    Nicola S. Russell
    Laura J. van't Veer
    Breast Cancer Research and Treatment, 2004, 83 : 91 - 93
  • [7] Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers
    Broeks, A
    de Witte, L
    Nooijen, A
    Huseinovic, A
    Klijn, JGM
    van Leeuwen, FE
    Russell, NS
    van't Veer, LJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) : 91 - 93
  • [8] A Case of Male Breast Cancer Patient with CHEK2*1100delC Mutation
    Nguyen, Quan D.
    Tavana, Anahita
    Rios, Florentino Saenz
    Monetto, Flavia E. Posleman
    Robinson, Angelica S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [9] Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
    M Kriege
    A Hollestelle
    A Jager
    P E A Huijts
    E M Berns
    A M Sieuwerts
    M E Meijer-van Gelder
    J M Collée
    P Devilee
    M J Hooning
    J W M Martens
    C Seynaeve
    British Journal of Cancer, 2014, 111 : 1004 - 1013
  • [10] CHEK2 1100delC and male breast cancer in the Netherlands
    Marijke Wasielewski
    Michael A. den Bakker
    Ans van den Ouweland
    Marion E. Meijer-van Gelder
    Henk Portengen
    Jan G. M. Klijn
    Hanne Meijers-Heijboer
    John A. Foekens
    Mieke Schutte
    Breast Cancer Research and Treatment, 2009, 116 : 397 - 400
12345